跳至主要内容
临床试验/ACTRN12607000108415
ACTRN12607000108415已完成不适用

Antihypertensive effects and side effects of Atenolol, Captopril, Nifidipine Sustained Release and Hydrochlorothiazide relative to the gene polymorphisms in untreated hypertensive patients in Rural China

Cardiovascular Institute, Chinese Academy of Medical Sciences0 个研究点目标入组 4,000 人开始时间: 2007年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 75 Years(—)
性别
All

入选标准

  • Untreated hypertensive patients, including those with newly diagnosed hypertension ( systolic/diastolic blood pressure >=160/95mmHg at two visits), and those with history of hypertension but not receiving antihypertensive treatment for at least 8 weeks (systolic/diastolic blood pressure >=140/90mmHg at two visits).

排除标准

  • Secondary hypertension; contraindication to any studied drugs; serum potassium values<3.5mEq/L or >5.5mEq/L at screening stage; requirement for any study drugs for reasons other than hypertension; low likelihood of compliance with protocol (eg, dementia, substance abuse); and a history of any severe, life-threatening disease within the past 3 years.

研究者

发起方
Cardiovascular Institute, Chinese Academy of Medical Sciences

相似试验